Abstract
Radioiodide is an effective therapy for thyroid cancer. This treatment modality exploits the thyroid-specific expression of the sodium iodide symporter ( NIS ) gene, which allows rapid internalization of iodide into thyroid cells. To test whether a similar treatment strategy could be exploited in nonthyroid malignancies, we transfected non–small cell lung cancer (NSCLC) cell lines with the NIS gene. Although the expression of NIS allowed significant radioiodide uptake in the transfected NSCLC cell lines, rapid radioiodide efflux limited tumor cell killing. Because thyroperoxidase ( TPO ) catalyzes iodination of proteins and subsequently causes iodide retention within thyroid cells, we hypothesized that coexpression of both NIS and TPO genes would overcome this deficiency. Our results show that transfection of NSCLC cells with both human NIS and TPO genes resulted in an increase in radioiodide uptake and retention and enhanced tumor cell apoptosis. These findings suggest that single gene therapy with only the NIS gene may have limited efficacy because of rapid efflux of radioiodide. In contrast, the combination of NIS and TPO gene transfer, with resulting TPO-mediated organification and intracellular retention of radioiodide, may lead to more effective tumor cell death. Thus, TPO could be used as a therapeutic strategy to enhance the NIS-based radioiodide concentrator gene therapy for locally advanced lung cancer. Cancer Gene Therapy (2001) 8, 612–618
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Franceschi S, Bidoli E . The epidemiology of lung cancer Ann Oncol 1999 5: (Suppl) S3–6
Pandey M, Mathew A, Nair MK . Global perspective of tobacco habits and lung cancer: a lesson for third world countries Eur J Cancer Prev 1999 8: 271–279
Trapasso F, Iuliano R, Chiefari E, et al . Iodide symporter gene expression in normal and transformed rat thyroid cells Eur J Endocrinol 1999 140: 447–451
Nilsson M . Molecular and cellular mechanisms of transepithelial iodide transport in the thyroid Biofactors 1999 10: 277–285
Filetti S, Bidart JM, Arturi F, Caillou B, Russo D, Schlumberger M . Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism Eur J Endocrinol 1999 141: 443–457
Lazar V, Bidart JM, Caillou B, et al . Expression of the Na+/I-symporter gene in human thyroid tumors: a comparison study with other thyroid-specific genes J Clin Endocrinol Metab 1999 84: 3228–3234
Reiners C, Farahati J . 131I therapy of thyroid cancer patients QJ Nucl Med 1999 43: 324–335
Uyttersprot N, Pelgrims N, Carrasco N, et al . Moderate doses of iodide in vivo inhibit cell proliferation and the expression of thyroperoxidase and Na+/I-symporter mRNAs in dog thyroid Mol Cell Endocrinol 1997 131: 195–203
Ajjan RA, Kamaruddin NA, Crisp M, Watson PF, Ludgate M, Weetman AP . Regulation and tissue distribution of the human sodium iodide symporter gene Clin Endocrinol (Oxford) 1998 49: 517–523
Mandell RB, Mandell LZ, Link CJ Jr . Radioisotope concentrator gene therapy using the sodium/iodide symporter gene Cancer Res 1999 59: 661–668
Boland A, Ricard M, Opolon P, et al . Adenovirus-mediated transfer of the thyroid sodium/iodide symporter gene into tumors for a targeted radiotherapy Cancer Res 2000 60: 3484–3492
Spitzweg C, Zhang S, Bergert ER, et al . Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines Cancer Res 1999 59: 2136–2141
Spitzweg C, Joba W, Eisenmenger W, Heufelder AE . Analysis of human sodium iodide symporter gene expression in extra-thyroidal tissues and cloning of its complementary deoxyribonucleic acids from salivary gland, mammary gland, and gastric mucosa J Clin Endocrinol Metab 1998 83: 1746–1751
Dubinett SM, Huang M, Dhanani S, Wang J, Beroiza T . Down-regulation of macrophage transforming growth factor-beta messenger RNA expression by IL-7 J Immunol 1993 151: 6670–6680
Saito T, Endo T, Kawaguchi A, et al . Increased expression of the Na+/I-symporter in cultured human thyroid cells exposed to thyrotropin and in Graves' thyroid tissue J Clin Endocrinol Metab 1997 82: 3331–3336
Yeang HY, Yusof F, Abdullah L . Precipitation of Hevea brasiliensis latex proteins with trichloroacetic acid and phosphotungstic acid in preparation for the Lowry protein assay Anal Biochem 1995 226: 35–43
Orgiazzi J, Millot L . Theoretical aspects of the treatment with antithyroid drugs Ann Endocrinol (Paris) 1999 55: 1–5
Dynlacht JR, Earles M, Henthorn J, et al . Degradation of the nuclear matrix is a common element during radiation-induced apoptosis and necrosis Radiat Res 1999 152: 590–603
Huang M, Wang J, Lee P, et al . Human non–small cell lung cancer cells express a type 2 cytokine pattern Cancer Res 1995 55: 3847–3853
Kogai T, Schultz JJ, Johnson LS, Huang M, Brent GA . Retinoic acid induces sodium/iodide symporter gene expression and radioiodide uptake in the MCF-7 breast cell line Proc Natl Acad Sci USA 2000 97: 8519–8524
Acknowledgements
This work is supported by National Institutes of Health Specialized Program of Research Excellence in Lung Cancer IP50CA90388 (S.M.D.), R01 CA71818 (S.M.D.), R01 CA085686 (S.M.D.), R01 CA78654 (R.K.B.), Medical Research Funds from the Department of Veteran Affairs, the Research Enhancement Award Program in Cancer Gene Medicine, and the Tobacco-Related Disease Research Program of the University of California.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Huang, M., Batra, R., Kogai, T. et al. Ectopic expression of the thyroperoxidase gene augments radioiodide uptake and retention mediated by the sodium iodide symporter in non–small cell lung cancer. Cancer Gene Ther 8, 612–618 (2001). https://doi.org/10.1038/sj.cgt.7700354
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.cgt.7700354
Keywords
This article is cited by
-
Network analysis reveals essential proteins that regulate sodium-iodide symporter expression in anaplastic thyroid carcinoma
Scientific Reports (2020)
-
5-Azacytidine inhaled dry powder formulation profoundly improves pharmacokinetics and efficacy for lung cancer therapy through genome reprogramming
British Journal of Cancer (2020)
-
Glial fibrillary acidic protein promoters direct adenovirus early 1A gene and human telomerase reverse transcriptase promoters direct sodium iodide symporter expression for malignant glioma radioiodine therapy
Molecular and Cellular Biochemistry (2015)
-
Comparison of radioactive iodide uptake in the rat thyroid between oral and intravenous bolus administration
Annals of Nuclear Medicine (2014)
-
Seeing Stem Cells at Work In Vivo
Stem Cell Reviews and Reports (2014)